2 – 5 April 2026,
Athenaeum Intercontinental, Αthens.
IASIS PHARMA participated in the 21st Panhellenic Conference of Dermatology & Venereology «The Skin Enigma» held on 2 to 5 April 2026, at the Athenaeum Intercontinental hotel.
The conference was organized by the Hellenic Society of Dermatology and Venereology.
Many Dermatologists attended the congress and had the chance to visit IASIS PHARMA exhibition stand and got informed of 4 important IASIS Dermatological products:
- Isotroin®/ Isotretinoin, indicated for severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. Isotroin® 30mg is added to the range of the other Isotroin® strengths (10mg, 20mg & 40mg).
- Combi®, a combination of fluprednidene (1mg) + miconazole (20mg) cream for the treatment of Inflammatory Dermatomycoses.
- Modiwart®/Ιmiquimod (12,5mg/sach), an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.
- Mastiha var. Chia Αναπλαστικό & Καταπραϋντικό Gel (30ml), which is used in minor skin inflammations and as an aid in the healing of microtraumas, because since 2015, Chios mastic gum has been officially recognized by the European Medicines Agency (EMA) as Herbal Medicine with the indication: Skin Inflammation & Skin Wound Healing (cutaneous use).
The Skin Enigma, 2026
